Hebei Changshan Biochemical Hits Day Low at CNY 37.15 Amid Price Pressure

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. experienced a significant decline in its stock price today, dropping by 5.8% and reaching an intraday low of CNY 37.15. This performance stands in stark contrast to the China Shanghai Composite, which saw a modest decrease of 0.42% on the same day. Over the past week, Hebei Changshan has seen a decline of 2.7%, while its performance over the last month has been even more pronounced, with a drop of 18.66%. Year-to-date, the stock has faced a substantial decrease of 39.63%, reflecting ongoing challenges within the company. In comparison, the China Shanghai Composite has remained relatively stable, with a slight increase of 0.61% year-to-date. The company's financial metrics indicate a weak long-term fundamental strength, highlighted by a negative return on equity of -30.22% and a concerning average return on capital employed (ROCE) of just 3.59%. Additionally, Hebei Changshan has reported negative results for the last four consecutive quarters, with a net profit of CNY -322.94 million for the first nine months, marking a decline of 62.45%. As the company navigates these financial hurdles, its stock continues to reflect the broader market's performance.